Ovid Therapeutics regains compliance with Nasdaq minimum bid price rule

Ovid Therapeutics Inc.

Received formal notice from Nasdaq on Sept 11, 2025, confirming compliance with Listing Rule 5550(a)(2).
Minimum bid price had been below $1.00; company now meets the requirement.
Nasdaq has closed the matter; no further action needed regarding listing status.
Stock trading symbol OVID remains on The Nasdaq Stock Market LLC.

item 8.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.